Administrative Core
行政核心
基本信息
- 批准号:9795000
- 负责人:
- 金额:$ 186.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-15 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAdvisory CommitteesAlzheimer disease detectionAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAmericanBiological MarkersBrainBudgetsChemicalsClinicalClinical TrialsCollectionCommunicationCommunitiesDataData AnalysesData SourcesDatabasesDementiaDoctor of PhilosophyEnsureFundingGeneticGoalsHome environmentInformaticsInfrastructureInternetLeadLeadershipMachine LearningMedicineMetadataMetagenomicsModelingNeurologistOccupational activity of managing financesPathogenesisPatient CarePhenotypePlanet EarthProtocols documentationResearchResearch PersonnelResource AllocationResourcesRoleRunningSamplingScheduleScientistSiteSpecimenStructureTechnologyTeleconferencesTimeUnited States National Institutes of HealthWorkbiochemical modelclinical research sitedata integrationdata managementdata sharingdeep learningdigital object identifierexperiencegut microbiomemeetingsmetabolomicsmicrobiomemicrobiome analysismultimodalityneuroimagingneuropsychiatric disorderoperationprogramsrelational databaserepositorysample collectionsuccesstool
项目摘要
ABSTRACT – Administrative Core
The Admin Core will provide structure and oversight to enable the Alzheimer’s Gut Microbiome Project to
achieve its goal to define the gut-brain-chemical axis of communication and the role for the gut microbiome in
Alzheimer’s Disease (AD) pathogenesis. This Core is co-led by Duke’s Rima Kaddurah-Daouk, PhD, UCSD’s
Robert Knight, PhD, and UCLA’s Sarkis Mazmanian, PhD, who bring considerable leadership experience and
complementary scientific expertise to the U19. Dr. Kaddurah-Daouk will serve as contact PI, and brings
experience having successfully led four large NIH-funded consortia and is a pioneer in the application of
metabolomics in neuropsychiatric diseases, including defining a role for the gut microbiome in AD. Dr. Knight
runs the Earth Microbiome Project and American Gut Project and developed microbiome technologies widely
used in the field. Dr. Mazmanian discovered a role for the gut microbiome in the pathogenesis of
neuropsychiatric diseases. This team is uniquely qualified to lead and coordinate this large program. Three
clinical AD experts (Drs. James Brewer, Andrew Saykin, and Murali Doraiswamy) will provide oversight for all
clinical activities including samples collection for national AD research centers and flow of samples through the
National Centralized Repository for AD and Related Dementias (NCRAD) center. Through its three Aims, the
Admin Core will ensure all Projects and Cores function as an efficient, effective, and integrated whole that all
components of the U19 have access to the tools and resources necessary to do the proposed work, and that
scientific progress is rapid, rigorous, and efficient. This Core will interact with all U19 Projects and Cores
through oversight, governance, and management. Main objectives of the Admin core are the integration of data
developed by collaborators through the creation of a relational database to manage all data-related activities
as well as the creation of a repository of uniformly collected biospecimens at the NCRAD which will be made
available to collaborators as well as the greater research community. Through our discussions, this Core will
facilitate rigorous oversight of research and data interpretation. Thus this Core’s activities are critical to our
collective success.
抽象--管理核心
管理核心将提供结构和监督,使阿尔茨海默氏症肠道微生物组项目能够
实现定义肠道-脑-化学轴的目标以及肠道微生物群在
阿尔茨海默病(AD)的发病机制。这个核心是由杜克大学的Rima Kaddurah-Daouk,博士,UCSD的共同领导的
罗伯特·奈特博士和加州大学洛杉矶分校的Sarkis Mazmanian博士,他们带来了丰富的领导经验和
与U19相辅相成的科学专长。Kaddurah-Daouk博士将担任联系人Pi,并带来
成功领导了四个由美国国立卫生研究院资助的大型财团,是应用
神经精神疾病的代谢组学,包括确定肠道微生物组在AD中的作用。奈特博士
主持地球微生物组计划和美国肠道计划,广泛开发微生物组技术
在野外使用。马兹马尼亚博士发现肠道微生物群在霍乱的发病机制中发挥了作用。
神经精神疾病。这个团队是唯一有资格领导和协调这一大型项目的团队。三
临床AD专家(詹姆斯·布鲁尔、安德鲁·塞金和穆拉利·多莱斯瓦米博士)将为所有
临床活动包括为国家AD研究中心收集样本和通过
国家AD及相关痴呆症中央资料库(NCRAD)中心。通过它的三个目标,
管理核心将确保所有项目和核心作为一个高效、有效和集成的整体运行
U19的部件可以获得完成拟议工作所需的工具和资源,并且
科学进步是快速、严谨、高效的。该核心将与所有U19项目和核心互动
通过监督、治理和管理。管理核心的主要目标是整合数据
由协作者通过创建关系数据库来开发,以管理所有与数据相关的活动
以及在NCRAD创建一个统一收集的生物标本储存库,这将使
可供合作者以及更大的研究社区使用。通过我们的讨论,这个核心将
促进对研究和数据解释的严格监督。因此,这个核心的活动对我们的
集体成功。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rima F Kaddurah-Daouk其他文献
Rima F Kaddurah-Daouk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rima F Kaddurah-Daouk', 18)}}的其他基金
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD
AMP-AD 中疾病亚分类和目标优先级的代谢组学特征
- 批准号:
10084547 - 财政年份:2020
- 资助金额:
$ 186.56万 - 项目类别:
Project 3 - Mechanistic studies on role of gut microbiome in models for Alzheimer's disease
项目 3 - 肠道微生物组在阿尔茨海默病模型中作用的机制研究
- 批准号:
9795005 - 财政年份:2019
- 资助金额:
$ 186.56万 - 项目类别:
Project 3 - Mechanistic studies on role of gut microbiome in models for Alzheimer's disease
项目 3 - 肠道微生物组在阿尔茨海默病模型中作用的机制研究
- 批准号:
10017880 - 财政年份:2019
- 资助金额:
$ 186.56万 - 项目类别:
Project 2 - Influence of controlled diets on gut microbiome, metabolome and cognitive function
项目 2 - 控制饮食对肠道微生物组、代谢组和认知功能的影响
- 批准号:
9795004 - 财政年份:2019
- 资助金额:
$ 186.56万 - 项目类别:
Project 2 - Influence of controlled diets on gut microbiome, metabolome and cognitive function
项目 2 - 控制饮食对肠道微生物组、代谢组和认知功能的影响
- 批准号:
10017878 - 财政年份:2019
- 资助金额:
$ 186.56万 - 项目类别:
Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease
项目 1 - 阿尔茨海默氏病轨迹中肠道微生物组和相关代谢组的变化
- 批准号:
10017875 - 财政年份:2019
- 资助金额:
$ 186.56万 - 项目类别:
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 186.56万 - 项目类别:
Standard Grant














{{item.name}}会员




